Evaluation of the effects of favipiravir (T-705) on the lung tissue of healty rats: An experimental study

Ülger et al., Food and Chemical Toxicology, doi:10.1016/j.fct.2025.115235, Jan 2025
Animal study showing dose-dependent lung inflammation and fibrosis with favipiravir.
Potential risks of favipiravir include kidney injury1-3, liver injury2-5, cardiovascular events5,6, pulmonary toxicity6,7, and mutagenicity, carcinogenicity, teratogenicity, embryotoxicity, and the creation of dangerous variants8-14.
Ülger et al., 11 Jan 2025, peer-reviewed, 7 authors.
DOI record: { "DOI": "10.1016/j.fct.2025.115235", "ISSN": [ "0278-6915" ], "URL": "http://dx.doi.org/10.1016/j.fct.2025.115235", "alternative-id": [ "S0278691525000018" ], "article-number": "115235", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Evaluation of the effects of favipiravir (T-705) on the lung tissue of healty rats: An experimental study" }, { "label": "Journal Title", "name": "journaltitle", "value": "Food and Chemical Toxicology" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.fct.2025.115235" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies." } ], "author": [ { "ORCID": "https://orcid.org/0000-0003-0108-7948", "affiliation": [], "authenticated-orcid": false, "family": "Ülger", "given": "Menekşe", "sequence": "first" }, { "ORCID": "https://orcid.org/0000-0002-7737-2553", "affiliation": [], "authenticated-orcid": false, "family": "Ülger", "given": "Birkan", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-3127-2207", "affiliation": [], "authenticated-orcid": false, "family": "Turan", "given": "Işıl Tuğçe", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-2766-4312", "affiliation": [], "authenticated-orcid": false, "family": "Temel", "given": "Şahin", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-0541-8372", "affiliation": [], "authenticated-orcid": false, "family": "Yay", "given": "Arzu", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-1935-9403", "affiliation": [], "authenticated-orcid": false, "family": "Yalçın", "given": "Betül", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-5456-4579", "affiliation": [], "authenticated-orcid": false, "family": "Yakan", "given": "Birkan", "sequence": "additional" } ], "container-title": "Food and Chemical Toxicology", "container-title-short": "Food and Chemical Toxicology", "content-domain": { "crossmark-restriction": true, "domain": [ "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2025, 1, 2 ] ], "date-time": "2025-01-02T17:13:00Z", "timestamp": 1735837980000 }, "deposited": { "date-parts": [ [ 2025, 6, 2 ] ], "date-time": "2025-06-02T22:41:03Z", "timestamp": 1748904063000 }, "funder": [ { "DOI": "10.13039/501100003062", "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100003062", "id-type": "DOI" } ], "name": "Erciyes Üniversitesi" }, { "DOI": "10.13039/501100016209", "award": [ "TSA-2022-11344" ], "award-info": [ { "award-number": [ "TSA-2022-11344" ] } ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100016209", "id-type": "DOI" } ], "name": "Erciyes University Scientific Research Projects Coordination Unit" } ], "indexed": { "date-parts": [ [ 2025, 11, 12 ] ], "date-time": "2025-11-12T14:26:54Z", "timestamp": 1762957614607, "version": "3.41.0" }, "is-referenced-by-count": 2, "issued": { "date-parts": [ [ 2025, 2 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 2, 1 ] ], "date-time": "2025-02-01T00:00:00Z", "timestamp": 1738368000000 } }, { "URL": "https://www.elsevier.com/legal/tdmrep-license", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 2, 1 ] ], "date-time": "2025-02-01T00:00:00Z", "timestamp": 1738368000000 } }, { "URL": "https://doi.org/10.15223/policy-017", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 2, 1 ] ], "date-time": "2025-02-01T00:00:00Z", "timestamp": 1738368000000 } }, { "URL": "https://doi.org/10.15223/policy-037", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 2, 1 ] ], "date-time": "2025-02-01T00:00:00Z", "timestamp": 1738368000000 } }, { "URL": "https://doi.org/10.15223/policy-012", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 2, 1 ] ], "date-time": "2025-02-01T00:00:00Z", "timestamp": 1738368000000 } }, { "URL": "https://doi.org/10.15223/policy-029", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 2, 1 ] ], "date-time": "2025-02-01T00:00:00Z", "timestamp": 1738368000000 } }, { "URL": "https://doi.org/10.15223/policy-004", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 2, 1 ] ], "date-time": "2025-02-01T00:00:00Z", "timestamp": 1738368000000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0278691525000018?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0278691525000018?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "115235", "prefix": "10.1016", "published": { "date-parts": [ [ 2025, 2 ] ] }, "published-print": { "date-parts": [ [ 2025, 2 ] ] }, "publisher": "Elsevier BV", "reference": [ { "author": "Andrea", "key": "10.1016/j.fct.2025.115235_bib1", "volume": "vol. 107", "year": "2010" }, { "DOI": "10.3899/jrheum.101144", "article-title": "Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies", "author": "Airo", "doi-asserted-by": "crossref", "first-page": "1329", "issue": "7", "journal-title": "J. Rheumatol.", "key": "10.1016/j.fct.2025.115235_bib2", "volume": "38", "year": "2011" }, { "DOI": "10.1016/j.intimp.2024.112292", "article-title": "Models in vivo and in vitro for the study of acute and chronic inflammatory activity: a comprehensive review", "author": "Bernardette Martínez-Rizo", "doi-asserted-by": "crossref", "journal-title": "Int. Immunopharm.", "key": "10.1016/j.fct.2025.115235_bib3", "volume": "135", "year": "2024" }, { "DOI": "10.5858/arpa.2015-0519-RA", "article-title": "Acute lung injury: a clinical and molecular review", "author": "Butt", "doi-asserted-by": "crossref", "first-page": "345", "issue": "4", "journal-title": "Arch. Pathol. Lab Med.", "key": "10.1016/j.fct.2025.115235_bib4", "volume": "140", "year": "2016" }, { "DOI": "10.3851/IMP1729", "article-title": "Maporal virus as a surrogate for pathogenic New World hantaviruses and its inhibition by favipiravir", "author": "Buys", "doi-asserted-by": "crossref", "first-page": "193", "issue": "5", "journal-title": "Antivir. Chem. Chemother.", "key": "10.1016/j.fct.2025.115235_bib5", "volume": "12", "year": "2011" }, { "article-title": "Experimental treatment with favipiravir for COVID-19: an open-label control study", "author": "Cai", "first-page": "1192", "issue": "10", "journal-title": "Engineering (Beijing) Oct", "key": "10.1016/j.fct.2025.115235_bib6", "volume": "6", "year": "2020" }, { "DOI": "10.1371/journal.pntd.0002790", "article-title": "Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever", "author": "Caroline", "doi-asserted-by": "crossref", "issue": "4", "journal-title": "PLoS Neglected Trop. Dis.", "key": "10.1016/j.fct.2025.115235_bib7", "volume": "10", "year": "2014" }, { "DOI": "10.2147/JIR.S275595", "article-title": "Reactive oxygen species: drivers of physiological and pathological processes", "author": "Checa", "doi-asserted-by": "crossref", "first-page": "1057", "journal-title": "J. Inflamm. Res.", "key": "10.1016/j.fct.2025.115235_bib8", "volume": "13", "year": "2020" }, { "article-title": "Pathobiology of pulmonary fibrosis", "author": "Crouch", "first-page": "L159", "issue": "4 Pt 1", "journal-title": "Am. J. Physiol.", "key": "10.1016/j.fct.2025.115235_bib9", "volume": "259", "year": "1990" }, { "DOI": "10.54817/IC.v65n1a08", "article-title": "Pulmonary toxicity associated with high-dose favipiravir and treatment options: biochemical and histopathological evaluation", "author": "Elma", "doi-asserted-by": "crossref", "first-page": "83", "issue": "1", "journal-title": "Invest. Clin.", "key": "10.1016/j.fct.2025.115235_bib10", "volume": "65", "year": "2024" }, { "DOI": "10.1002/jbt.23536", "article-title": "Assessment of toxicological effects of favipiravir (T-705) on the lung tissue of rats: an experimental study", "author": "Erbaş", "doi-asserted-by": "crossref", "issue": "1", "journal-title": "J. Biochem. Mol. Toxicol.", "key": "10.1016/j.fct.2025.115235_bib11", "volume": "38", "year": "2024" }, { "DOI": "10.1016/S0953-6205(00)00068-6", "article-title": "Leukocyte activation and cytokine production during experimental human endotoxemia", "author": "Fijen", "doi-asserted-by": "crossref", "first-page": "89", "issue": "2", "journal-title": "Eur. J. Intern. Med.", "key": "10.1016/j.fct.2025.115235_bib12", "volume": "11", "year": "2000" }, { "DOI": "10.1016/j.antiviral.2013.09.015", "article-title": "Favipiravir (T-705), a novel viral RNA polymerase inhibitor", "author": "Furuta", "doi-asserted-by": "crossref", "first-page": "446", "issue": "2", "journal-title": "Antivir. Res.", "key": "10.1016/j.fct.2025.115235_bib13", "volume": "100", "year": "2013" }, { "DOI": "10.1128/AAC.49.3.981-986.2005", "article-title": "Mechanism of action of T-705 against influenza virus", "author": "Furuta", "doi-asserted-by": "crossref", "first-page": "981", "issue": "3", "journal-title": "Antimicrob. Agents Chemother.", "key": "10.1016/j.fct.2025.115235_bib14", "volume": "49", "year": "2005" }, { "DOI": "10.1038/ki.1992.75", "article-title": "The biology of the myofibroblast", "author": "Gabbiani", "doi-asserted-by": "crossref", "first-page": "530", "issue": "3", "journal-title": "Kidney Int. Mar", "key": "10.1016/j.fct.2025.115235_bib15", "volume": "41", "year": "1992" }, { "DOI": "10.1055/a-1296-7935", "article-title": "Favipiravir and COVID-19: a simplified summary", "author": "Ghasemnejad-Berenji", "doi-asserted-by": "crossref", "first-page": "166", "issue": "3", "journal-title": "Drug Res.", "key": "10.1016/j.fct.2025.115235_bib16", "volume": "71", "year": "2021" }, { "DOI": "10.1016/j.antiviral.2009.10.015", "article-title": "Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models", "author": "Gowen", "doi-asserted-by": "crossref", "first-page": "121", "issue": "2", "journal-title": "Antivir. Res.", "key": "10.1016/j.fct.2025.115235_bib17", "volume": "86", "year": "2010" }, { "DOI": "10.1016/j.toxlet.2022.09.011", "article-title": "Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells", "author": "Gunaydin-Akyildiz", "doi-asserted-by": "crossref", "first-page": "9", "journal-title": "Toxicol. Lett.", "key": "10.1016/j.fct.2025.115235_bib18", "volume": "371", "year": "2022" }, { "DOI": "10.1080/14787210.2021.1866545", "article-title": "A review on favipiravir: the properties, function, and usefulness to treat COVID-19", "author": "Hashemian", "doi-asserted-by": "crossref", "first-page": "1029", "issue": "8", "journal-title": "Expert Rev. Anti Infect. Ther.", "key": "10.1016/j.fct.2025.115235_bib19", "volume": "19", "year": "2021" }, { "key": "10.1016/j.fct.2025.115235_bib20", "unstructured": "Information provided by Dr. Reddy's Laboratories Limited. Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients. Responsible. s.l. : National library of medicine. Mar. https://beta.clinicaltrials.gov/study/NCT04529499?tab=results." }, { "DOI": "10.1038/aps.2016.36", "article-title": "Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway", "author": "Ji", "doi-asserted-by": "crossref", "first-page": "794", "issue": "6", "journal-title": "Acta Pharmacol. Sin.", "key": "10.1016/j.fct.2025.115235_bib21", "volume": "37", "year": "2016" }, { "DOI": "10.1073/pnas.2014441117", "article-title": "Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity", "author": "Kaptein", "doi-asserted-by": "crossref", "first-page": "26955", "issue": "43", "journal-title": "Proc. Natl. Acad. Sci. U. S. A.", "key": "10.1016/j.fct.2025.115235_bib22", "volume": "27", "year": "2020" }, { "DOI": "10.1080/01480545.2022.2066116", "article-title": "Evaluation of the toxicological effects of favipiravir (T-705) on liver and kidney in rats: biochemical and histopathological approach", "author": "Kara", "doi-asserted-by": "crossref", "first-page": "546", "issue": "3", "journal-title": "Drug Chem. Toxicol.", "key": "10.1016/j.fct.2025.115235_bib23", "volume": "46", "year": "2023" }, { "DOI": "10.1073/pnas.0605669103", "article-title": "Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix", "author": "Kim", "doi-asserted-by": "crossref", "first-page": "13180", "issue": "35", "journal-title": "Proc. Natl. Acad. Sci. U. S. A.", "key": "10.1016/j.fct.2025.115235_bib24", "volume": "29", "year": "2006" }, { "DOI": "10.5152/eajm.2013.08", "article-title": "Tissue damage and oxidant/antioxidant balance", "author": "Kisaoglu", "doi-asserted-by": "crossref", "first-page": "47", "issue": "1", "journal-title": "Eurasian J MedFeb", "key": "10.1016/j.fct.2025.115235_bib25", "volume": "45", "year": "2013" }, { "DOI": "10.3390/jcm10020273", "article-title": "Favipiravir in therapy of viral infections", "author": "Łagocka", "doi-asserted-by": "crossref", "first-page": "273", "issue": "2", "journal-title": "J. Clin. Med.", "key": "10.1016/j.fct.2025.115235_bib26", "volume": "13", "year": "2021" }, { "DOI": "10.1016/S0300-483X(00)00437-6", "article-title": "Role of macrophages and inflammatory mediators in chemically induced toxicity", "author": "Laskin", "doi-asserted-by": "crossref", "first-page": "111", "issue": "1–3", "journal-title": "Toxicology", "key": "10.1016/j.fct.2025.115235_bib27", "volume": "7", "year": "2001" }, { "DOI": "10.1134/S0022093022020119", "article-title": "Evaluation of the effects of favipiravir combined with vitamin C on alveolar bone in rats", "author": "Lektemur Alpan", "doi-asserted-by": "crossref", "first-page": "430", "issue": "2", "journal-title": "J. Evol. Biochem. Physiol.", "key": "10.1016/j.fct.2025.115235_bib28", "volume": "58", "year": "2022" }, { "DOI": "10.1007/s40262-015-0364-1", "article-title": "Ebola virus infection: review of the pharmacokinetic and pharmacodynamic properties of drugs considered for testing in human efficacy trials", "author": "Madelain", "doi-asserted-by": "crossref", "first-page": "907", "issue": "8", "journal-title": "Clin. Pharmacokinet.", "key": "10.1016/j.fct.2025.115235_bib29", "volume": "55", "year": "2016" }, { "DOI": "10.1186/s12879-021-06164-x", "article-title": "Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis", "author": "Manabe", "doi-asserted-by": "crossref", "first-page": "489", "issue": "1", "journal-title": "BMC Infect. Dis.", "key": "10.1016/j.fct.2025.115235_bib30", "volume": "21", "year": "2021" }, { "DOI": "10.1006/cyto.1999.0517", "article-title": "Interleukin 8 production in whole blood assays: is interleukin 10 responsible for the downregulation observed in sepsis?", "author": "Marie", "doi-asserted-by": "crossref", "first-page": "55", "issue": "1", "journal-title": "Cytokine", "key": "10.1016/j.fct.2025.115235_bib31", "volume": "12", "year": "2000" }, { "DOI": "10.1152/ajplung.00313.2007", "article-title": "Murine models of pulmonary fibrosis", "author": "Moore", "doi-asserted-by": "crossref", "first-page": "L152", "issue": "2", "journal-title": "Am. J. Physiol. Lung Cell Mol. Physiol Feb.", "key": "10.1016/j.fct.2025.115235_bib32", "volume": "294", "year": "2008" }, { "DOI": "10.1038/nm1091", "article-title": "Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity", "author": "Moyron-Quiroz", "doi-asserted-by": "crossref", "first-page": "927", "issue": "9", "journal-title": "Nat. Med.", "key": "10.1016/j.fct.2025.115235_bib33", "volume": "10", "year": "2004" }, { "DOI": "10.1097/00003246-200004001-00002", "article-title": "Cytokine signaling--regulation of the immune response in normal and critically ill states", "author": "Oberholzer", "doi-asserted-by": "crossref", "first-page": "N3", "issue": "4 Suppl. l", "journal-title": "Crit. Care Med.", "key": "10.1016/j.fct.2025.115235_bib34", "volume": "28", "year": "2000" }, { "DOI": "10.1182/blood.V90.4.1415", "article-title": "Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans", "author": "Pajkrt", "doi-asserted-by": "crossref", "first-page": "1415", "issue": "4", "journal-title": "Blood", "key": "10.1016/j.fct.2025.115235_bib35", "volume": "15", "year": "1997" }, { "DOI": "10.1186/s12931-018-0935-4", "article-title": "Inflammation and lung injury in an ovine model of fluid resuscitated endotoxemic shock", "author": "Passmore", "doi-asserted-by": "crossref", "first-page": "231", "issue": "1", "journal-title": "Respir. Res.", "key": "10.1016/j.fct.2025.115235_bib36", "volume": "22", "year": "2018" }, { "DOI": "10.1016/B978-0-12-381300-8.00007-1", "article-title": "Bronchus-associated lymphoid tissue (BALT) structure and function", "author": "Randall", "doi-asserted-by": "crossref", "first-page": "187", "journal-title": "Adv. Immunol.", "key": "10.1016/j.fct.2025.115235_bib37", "volume": "107", "year": "2010" }, { "DOI": "10.1172/JCI28756", "article-title": "Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis", "author": "Rangel-Moreno", "doi-asserted-by": "crossref", "first-page": "3183", "issue": "12", "journal-title": "J. Clin. Invest.", "key": "10.1016/j.fct.2025.115235_bib38", "volume": "116", "year": "2006" }, { "DOI": "10.1016/j.antiviral.2014.01.016", "article-title": "Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment", "author": "Scharton", "doi-asserted-by": "crossref", "first-page": "84", "journal-title": "Antivir. Res.", "key": "10.1016/j.fct.2025.115235_bib39", "volume": "104", "year": "2014" }, { "DOI": "10.7326/0003-4819-134-2-200101160-00015", "article-title": "American Thoracic Society; European Respiratory Society; American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy", "author": "Selman", "doi-asserted-by": "crossref", "first-page": "136", "issue": "2", "journal-title": "Ann. Intern. Med.", "key": "10.1016/j.fct.2025.115235_bib40", "volume": "16", "year": "2001" }, { "DOI": "10.1152/ajplung.2000.279.3.L562", "article-title": "TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?", "author": "Selman", "doi-asserted-by": "crossref", "first-page": "L562", "issue": "3", "journal-title": "Am. J. Physiol. Lung Cell Mol. Physiol.", "key": "10.1016/j.fct.2025.115235_bib41", "volume": "279", "year": "2000" }, { "DOI": "10.1016/j.pharmthera.2020.107512", "article-title": "Favipiravir, an anti-influenza drug against life-threatening RNA virus infections", "author": "Shiraki", "doi-asserted-by": "crossref", "journal-title": "Pharmacol. Ther.", "key": "10.1016/j.fct.2025.115235_bib42", "volume": "209", "year": "2020" }, { "DOI": "10.1128/AAC.01051-06", "article-title": "Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice", "author": "Sidwell", "doi-asserted-by": "crossref", "first-page": "845", "issue": "3", "journal-title": "Antimicrob. Agents Chemother.", "key": "10.1016/j.fct.2025.115235_bib43", "volume": "51", "year": "2007" }, { "DOI": "10.1016/j.etap.2015.02.019", "article-title": "The inflammasome accelerates radiation-induced lung inflammation and fibrosis in mice", "author": "Sohn", "doi-asserted-by": "crossref", "first-page": "917", "issue": "2", "journal-title": "Environ. Toxicol. Pharmacol.", "key": "10.1016/j.fct.2025.115235_bib44", "volume": "39", "year": "2015" }, { "DOI": "10.1016/j.antiviral.2012.03.001", "article-title": "Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice", "author": "Tarbet", "doi-asserted-by": "crossref", "first-page": "103", "issue": "1", "journal-title": "Antiviral Res. Apr.", "key": "10.1016/j.fct.2025.115235_bib45", "volume": "94", "year": "2012" }, { "DOI": "10.1016/j.jchemneu.2021.101958", "article-title": "The effect of erythropoietin and umbilical cord-derived mesenchymal stem cells on nerve regeneration in rats with sciatic nerve injury", "author": "Ülger", "doi-asserted-by": "crossref", "journal-title": "J. Chem. Neuroanat.", "key": "10.1016/j.fct.2025.115235_bib46", "volume": "114", "year": "2021" }, { "DOI": "10.1001/jama.2020.1585", "article-title": "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "1061", "issue": "11", "journal-title": "JAMA", "key": "10.1016/j.fct.2025.115235_bib47", "volume": "17", "year": "2020" }, { "DOI": "10.1152/ajplung.00163.2007", "article-title": "TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease", "author": "Willis", "doi-asserted-by": "crossref", "first-page": "L525", "issue": "3", "journal-title": "Am. J. Physiol. Lung Cell Mol. Physiol.", "key": "10.1016/j.fct.2025.115235_bib48", "volume": "293", "year": "2007" }, { "DOI": "10.1152/ajpcell.00328.2012", "article-title": "Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis", "author": "Zeisberg", "doi-asserted-by": "crossref", "first-page": "C216", "journal-title": "Am. J. Physiol. Cell Physiol.", "key": "10.1016/j.fct.2025.115235_bib50", "volume": "304", "year": "2013" }, { "article-title": "Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study", "author": "Zhang", "first-page": "114", "issue": "1", "journal-title": "Am. J. Pathol. Jul", "key": "10.1016/j.fct.2025.115235_bib51", "volume": "145", "year": "1994" }, { "DOI": "10.2174/0929867326666190620103813", "article-title": "Bioactivities of natural catalpol derivatives", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "6149", "issue": "33", "journal-title": "Curr. Med. Chem.", "key": "10.1016/j.fct.2025.115235_bib52", "volume": "26", "year": "2019" } ], "reference-count": 51, "references-count": 51, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0278691525000018" } }, "score": 1, "short-title": [], "source": "Crossref", "special_numbering": "C", "subject": [], "subtitle": [], "title": "Evaluation of the effects of favipiravir (T-705) on the lung tissue of healty rats: An experimental study", "type": "journal-article", "update-policy": "https://doi.org/10.1016/elsevier_cm_policy", "volume": "196" }
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit